← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

A

$ Value

$0

Shares

60,776

Price

$0

Filed

Mar 9

Insider

Name

Azamian Bobak R.

Title

President/CEO and Board Chair

CIK

0001827672

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-05

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,776

Footnotes

25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.

Filing Info

Accession No.

0001827672-26-000003

Form Type

4

Issuer CIK

0001819790

Azamian Bobak R.'s History

Date Ticker Type Value
2026-03-19 TARS $802K
2026-03-18 TARS $802K
2026-03-17 TARS $762K
2026-03-15 TARS M
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-05 TARS A $0
2026-03-05 TARS A $0

Other Insiders at TARS (90d)

Insider Bought Sold Last
PYOTT DAVID E I 2026-02-18
LINK WILLIAM J PHD $860K 2026-03-16
Farrow Jeffrey S
See Remarks
$440K 2026-03-19
Mottiwala Aziz
Chief Commercial Officer
$893K 2026-03-19
Neervannan Seshadri
Chief Operating Officer
$1.6M 2026-03-20
Azamian Bobak R.
President/CEO and Board Chair
$2.4M 2026-03-19
Whitfield Dianne C.
Chief Human Resources Officer
2026-03-15
Wahl Bryan
General Counsel
2026-03-15
Lin Elizabeth Yeu
Chief Medical Officer
$78K 2026-03-19